Anavex Life Sciences Corp. (AVXL)

1d ago, source: Yahoo Finance

Anavex Life Sciences (AVXL) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Shareholders that lost money on Anavex Life Sciences Corporation(AVXL) Urged to Join Class Action - Contact The Gross Law Firm to Learn More

7d ago, source:

NDAQ:AVXL) Shareholders that lost money on Anavex Life Sciences Corporation(AVXL) Urged to Join Class Action - Contact The ...

Investors who lost money on Anavex Life Sciences Corporation(AVXL) should contact Levi & Korsinsky about pending Class Action - AVXL

10d ago, source: KELOLAND News

THE LAWSUIT: A class action securities lawsuit was filed against Anavex Life Sciences Corporation that seeks to recover losses of shareholders who were adversely affected by alleged securities ...

Buy Rating on Anavex Life Sciences Amid Promising Alzheimer’s Drug Prospects

8d ago, source:

Anavex Life Sciences (AVXL – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst ...

Anavex Life Sciences Corp. (AVXL)

1d ago, source: Yahoo Finance

NEW YORK, April 11, 2024 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated ...

Anavex Life Sciences Corp. (AVXL) Q2 2024 Earnings Call Transcript

8d ago, source: Seeking Alpha

And welcome to the Anavex Life Sciences Fiscal 2024 Second Quarter ... Before we begin please note that during this conference call the company will make some projections and forward-looking ...